期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Biochemia Medica LetPub Score 6.3
50 ratings
Rate
Reputation 7.6 Influence 4.8 Speed 9.1 | ||||||||||||||||||||
期刊簡稱 | BIOCHEM MEDICA | ||||||||||||||||||||
ISSN | 1330-0962 | ||||||||||||||||||||
h-index | 35 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.biochemia-medica.com/ | ||||||||||||||||||||
在線稿件提交 | http://www.editorialmanager.com/biochemmed/default.aspx | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Biochemia Medica, Editorial Office | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | CROATIA | ||||||||||||||||||||
發行頻率 | 半年刊行 | ||||||||||||||||||||
創刊年 | 1993 | ||||||||||||||||||||
每年文章數 | 36每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 88.37% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1330-0962%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Biochemia Medica] 的評論 | 撰寫評論 |
作者: 沐鑫守卫 領域: 医学 審稿時間: 6.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-05-27 17:06:52 評論於 The reviewer is very serious(0) 讚! | 沐鑫守卫 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:48:18 評論於 Contrary to the structure of the introduction and conclusion in the discussion section, it takes a funnel shape from small to large, gradually expanding. Starting from the rationality of each research result, anomalies, and the principles behind them, slowly analyze in depth. After laying the foundation, the main conclusion of the paper can be naturally introduced for discussion, followed by further analysis to point out the importance/significance/universality/application value of the research(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:52:30 評論於 There is no fixed requirement for paragraphing in this discussion. Please write according to your actual situation(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 17:37:16 評論於 How many paragraphs are usually used in a discussion?(0) 讚! | 龙鳞孝礼 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 15:18:52 評論於 What is the difference between an introduction and a discussion?(0) 讚! | 平原文波 |
作者: 藤原振营 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-11-15 20:08:45 評論於 I don't know if there is hope to enter a top journal this year. The reviewers selected by this journal are very meticulous, and they ask all questions very carefully(0) 讚! | 藤原振营 |
作者: Taban 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-11-15 11:48:38 評論於 The reviewers for this journal are extremely critical and it is time-consuming to address their comments. Honestly, not sure if I’m for up it again, although their reviews did strengthen my paper. (0) 讚! | Taban |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 15:59:47 評論於 The past was great, but the current drastic fall is quite frightening. I hope to return to a 3-point level next year, but it may be too difficult(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us